Evidence map›Paper›PMID 41224775›Full record

ArticleMicrosystems & nanoengineering2025

Integrated microoptical system for continuous fluorescence monitoring of microtissues.

Xu Tian, Hanie Kavand, Martin Köhler, Jessika Jessika, Reison Gjaci, Montse Visa, Per-Olof Berggren, Göran Stemme, Wouter van der Wijngaart, Anna Herland and 1 more

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xu Tian *Division of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID http://orcid.org/0009-0007-6016-3708
Hanie Kavand *Division of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.
Martin Köhler *The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Solna, Sweden.
Jessika JessikaDivision of Nanobiotechnology, Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Solna, Sweden.ORCID http://orcid.org/0000-0001-8433-2181
Reison GjaciDivision of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.
Montse VisaThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Solna, Sweden.
Per-Olof BerggrenThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Solna, Sweden.
Göran StemmeDivision of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.
Wouter van der WijngaartDivision of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8248-6670
Anna HerlandDivision of Nanobiotechnology, Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Solna, Sweden. aherland@kth.se.
Niclas RoxhedDivision of Micro and Nanosystems, Department of Intelligent Systems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden. roxhed@kth.se.ORCID http://orcid.org/0000-0002-7147-6730

Funding

Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research) RMX18-0066
6 · The paper itself

Abstract

Microphysiological systems (MPS) are advanced in vitro platforms engineered to replicate in vivo conditions for studying human biology, disease mechanisms, and drug responses with greater physiological relevance. Fluorescence sensing is widely used as a functional readout in MPS due to its high sensitivity, selectivity, and stability. However, conventional fluorescence sensing systems often rely on bulky instrumentation with limited integration, which restricts continuous in situ monitoring, scalable high-throughput analysis, and spatially resolved investigation in multi-organ-on-a-chip models. To address these limitations, we present a highly miniaturized, fully integrated optical system with a 1 mm² footprint, enabling continuous in situ fluorescence monitoring of three-dimensional microtissues in close proximity. The system integrates microscale illumination and sensing units for fluorescence excitation and selective detection, an optical element for guided light propagation, and a microcage for mechanical confinement of microtissues. To demonstrate its capabilities, we integrated the miniaturized optical system with an MPS-relevant platform to monitor fluorescence signals in transgenic mouse pancreatic islets expressing genetically encoded calcium indicators. The integrated platform enables real-time, continuous monitoring of islet responses to potassium chloride stimulation and tracking of calcium oscillations for over two hours, providing valuable information about the functional status of the pancreatic islets. Our work enhances the analytical capabilities of MPS through the integration of miniaturized on-chip quantitative assessment tools, enabling precise, in situ, and continuous monitoring of biological activities in close proximity.

Identifiers

PMID41224775
PMCPMC12612206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.